Error
  • JUser: :_load: Unable to load user with ID: 78
PUBLIC POLICY
ASM Policy efforts focus on communicating the importance of the microbial science to Congress, Federal Agencies and the Public.

On July 26, ASM joined the Clinical Laboratory Coalition (CLC) in a conference call to update members on current strategies to reverse the detrimental effects of the Protecting Access to Medicare Act of 2014 (PAMA) legislation, which will reduce laboratory test reimbursement.

On July 25, the Health Subcommittee of the House Energy and Commerce Committee held a hearing on implementation of the “21st Century Cures Act (Cures Act).” National Institutes of Health (NIH) Director Francis Collins and U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb were among the witnesses. Rep. Gene Green (D-TX) expressed concern with antibiotic resistance and development of an Ebola vaccine and Rep. Anna Eshoo (D-CA) asked about the priority review process for medical countermeasures (MCM).

ASM thanks the House Energy and Commerce Committee for its passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.

ASM joined members of the Clinical Laboratory Coalition in a letter to House and Senate committee leadership on the Diagnostic Accuracy and Innovation Act (DAIA) discussion draft.

ASM staff joined the Global Health Council and other stakeholders in a meeting with Robert Redfield to discuss broad priorities for the CDC in the coming years.

ASM submitted comments to the Centers for Medicare and Medicaid Services on payment for new codes which will be included in the 2019 Medicare Clinical Laboratory Fee Schedule (CLFS). New codes considered include several Borrelia diagnostic tests.

ASM joins laboratory societies in two letters on the Palmetto Draft Local Coverage Determinations on Multiplex Nucleic Acid Amplified Tests for Respiratory and Gastrointestinal Panels.

The ASM calls upon Congress to continue to make available the
balance of FY 2015 Ebola emergency funding, and to work through the FY 2019 appropriations
process to create a robust public health emergency contingency fund that allows the United
States to respond rapidly to Ebola and other pandemics that threaten our homeland.

The ASM Office of Public Affairs has prepared a document explaining science-related spending in the fiscal year 2018 Omnibus Spending Bill.

ASM drafted comments to the Centers for Medicare & Medicaid Services on Clinical Laboratory Improvement Amendments of 1988 (CLIA) personnel requirements and appropriate sanctions in situations where they determine that a laboratory has referred its proficiency testing samples to another laboratory.  ASM strongly recommends that all laboratory testing personnel meet the 24 semester hour science requirement for high complexity testing. 

The American Society for Microbiology issued the following statement in response to the President’s fiscal year (FY) 2019 budget released yesterday.

ASM signed on to a letter supporting increased 302b allocations for science research. The letter, signed by 95 businesses, universities, and science and engineering organizations, urges increases in CJS, E&W, and DOD science funding.

Check the latest update from HHS on what the shutdown means for the nation's top public health agencies. View the notice of activities to remain open and to be closed. 

ASM signed on to a letter in support of the Prevention and Public Health Fund. The letter was sent to congressional leadership on January 18th and was signed by 177 health and science groups.

Friday, 19 January 2018 12:47

Clinical Microbiology Issues Update - January 2018

Posted by:

The January issue of the Clinical Microbiology Issues Update has been published by the Office of Public Affairs.

The American Society for Microbiology is in complete support of the National Institutes of Health lifting the funding pause on gain-of-function (GoF) experiments involving influenza, SARS, and MERS viruses. 

The ASM signed on to a letter to the director of the Office of Management and Budget encouraging the heads of all federal agencies to support the use of science in decision making and to support the scientists who produce the knowledge upon which the nation’s economy relies.

The ASM supports the Centers for Disease Control and Prevention and the importance of evidence-based science to inform policy decisions surrounding prevention and defending the country from public health threats.

The December issue of the Minority Microbiology Mentor has been published by the Committee on Microbiological Issues Impacting Minorities

Tuesday, 05 December 2017 11:25

ASM Urges Increased Funding for CDC

The ASM participated in a coalition letter urging Congress to provide at least $7.8 billion for the Centers for Disease Control and Prevention’s programs as they work to develop a final FY 2018 Labor, Health and Human Services, Education and Related Agencies Appropriations bill or other final FY 2018 funding legislation.

Page 1 of 6

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH